Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
Primary Purpose
Alpha 1-Antitrypsin Deficiency
Status
Terminated
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Alpha 1-Antitrypsin Deficiency focused on measuring alpha 1-antitrypsin deficiency, genetic diseases and dysmorphic syndromes, rare disease
Eligibility Criteria
Alpha 1-antitrypsin deficiency
Sites / Locations
- Children's Hospital of Pittsburgh
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00005098
First Posted
April 6, 2000
Last Updated
June 23, 2005
Sponsor
National Center for Research Resources (NCRR)
Collaborators
University of Pittsburgh
1. Study Identification
Unique Protocol Identification Number
NCT00005098
Brief Title
Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
Study Type
Observational
2. Study Status
Record Verification Date
May 2002
Overall Recruitment Status
Terminated
Study Start Date
March 1999 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Center for Research Resources (NCRR)
Collaborators
University of Pittsburgh
4. Oversight
5. Study Description
Brief Summary
OBJECTIVES:
I. Establish cell lines from patients with alpha 1-antitrypsin deficiency in order to examine genetic traits that predispose to liver injury.
Detailed Description
PROTOCOL OUTLINE:
Patients undergo blood draw and skin biopsy. Cells are isolated from patients' blood and skin, cell lines are established, and genetic traits are examined.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alpha 1-Antitrypsin Deficiency
Keywords
alpha 1-antitrypsin deficiency, genetic diseases and dysmorphic syndromes, rare disease
7. Study Design
Enrollment
160 (false)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
0 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Alpha 1-antitrypsin deficiency
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David H. Perlmutter
Organizational Affiliation
University of Pittsburgh
Official's Role
Study Chair
Facility Information:
Facility Name
Children's Hospital of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
We'll reach out to this number within 24 hrs